Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Published species reactivity||Pig, Human, Not Applicable|
|Host / Isotype||Mouse / IgG1, kappa|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||10ul|
|Immunohistochemistry (Frozen) (IHC (F))||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-11569 targets CD54 in FACS and IHC (F) applications and shows reactivity with Human samples.
The MA5-11569 immunogen is human monocytes.
ICAM-1 (intercellular adhesion molecule) has 7 potential N-linked glycosylation sites. It is a single chain glycoprotein of Ig supergene family, present on unstimulated endo-thelial cells (EC) and on a variety of other cell types including activated fibroblasts, EC, macrophages, and lymphocytes. ICAM-1 mediates cell adhesion by binding to integrins CD11a/CD18 (leukocyte adhesion molecule, LFA-1) and to CD11b/CD18 (Mac-1). This interaction enhances antigen-specific T-cell activation. ICAM-1 also binds to CD43 and to Plasmodium falciparum infected RBCs.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
|Not Applicable||Not Cited||
Use of thermodynamic coupling between antibody-antigen binding and phospholipid acyl chain phase transition energetics to predict immunoliposome targeting affinity.
MA5-11569 was used in ELISA to study the use of thermodynamic analysis of antibody-antigen interactions and phospholipid phase transitions to better predict the targeting affinity of immunoliposomes
|Klegerman ME,Zou Y,Golunski E,Peng T,Huang SL,McPherson DD||Journal of liposome research (24:216)||2014|
Nitric oxide improves molecular imaging of inflammatory atheroma using targeted echogenic immunoliposomes.
MA5-11569 was used in immunohistochemistry to study the use of NO pretreatment of targeted echogenic immunoliposomes to improve atheroma penetration and visualization in imaging studies
|Kim H,Kee PH,Rim Y,Moody MR,Klegerman ME,Vela D,Huang SL,McPherson DD,Laing ST||Atherosclerosis (231:252)||2013|
Histopathologies, immunolocalization, and a glycan binding screen provide insights into Plasmodium falciparum interactions with the human placenta.
MA5-11569 was used in immunohistochemistry to study the mechanisms underlying the interaction of Plasmodium falciparum with the human placenta
|Hromatka BS,Ngeleza S,Adibi JJ,Niles RK,Tshefu AK,Fisher SJ||Biology of reproduction (88:null)||2013|
Palm tissue displaying a polyclonal autoimmune response in patients affected by a new variant of endemic pemphigus foliaceus in Colombia, South America.
MA5-11569 was used in immunohistochemistry to investigate pathological alterations in endemic pemphigus foliaceus in South America
|Abreu Velez AM,Howard MS,Hashimoto T||European journal of dermatology : EJD (20:74)||2010|
Expression of intercellular adhesion molecule-1 in umbilical and placental vascular tissue of gestational diabetic and normal pregnancies.
MA5-11569 was used in immunohistochemistry to examine the expression of intercellular adhesion molecule-1 in vascular tissue during pregnancy
|Kurt M,Zulfikaroglu E,Ucankus NL,Omeroglu S,Ozcan U||Archives of gynecology and obstetrics (281:71)||2010|
Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin.
MA5-11569 was used in immunocytochemistry to investigate the anti-inflammatory effect of angiogenesis inhibitor vasostatin
|Huegel R,Velasco P,De la Luz Sierra M,Christophers E,Schröder JM,Schwarz T,Tosato G,Lange-Asschenfeldt B||The Journal of investigative dermatology (127:65)||2007|
Intravascular ultrasound molecular imaging of atheroma components in vivo.
MA5-11569 was used in blocking or activating experiment to use intravascular ultrasound molecular imaging to study atheroma components in vivo
|Hamilton AJ,Huang SL,Warnick D,Rabbat M,Kane B,Nagaraj A,Klegerman M,McPherson DD||Journal of the American College of Cardiology (43:453)||2004|
BB2; cell surface glycoprotein P3.58; human rhinovirus receptor; ICAM-1; intercellular adhesion molecule 1; intercellular adhesion molecule 1 (CD54), human rhinovirus receptor; major group rhinovirus receptor; P3.58
BB2; CD54; ICAM1; P3.58